Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21

被引:64
|
作者
Kweonl, SoonHo [1 ]
Minh-Trang Thi Phan [2 ]
Chun, Sejong [3 ]
Yu, HongBi [4 ]
Kim, Jinho [4 ]
Kim, Seokho [5 ]
Lee, Jaemin [5 ]
Ali, Alaa Kassim [6 ]
Lee, Seung-Hwan [6 ]
Kim, Sang-Ki [7 ]
Doh, Junsang [8 ]
Cho, Duck [9 ,10 ,11 ]
机构
[1] POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea
[2] POSTECH, Dept Mech Engn, Pohang, South Korea
[3] Chonnam Natl Univ, Dept Lab Med, Gwangju, South Korea
[4] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[5] Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, Daejeon, South Korea
[6] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
[7] Kongju Natl Univ, Dept Compan, Lab Anim Sci, Yesan, South Korea
[8] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul, South Korea
[9] Sungkyunkwan Univ, Dept Lab Med & Genet, Samsung Med Ctr, Sch Med, Seoul, South Korea
[10] Samsung Med Ctr, Stem Celi & Regenerat Med Inst, Seoul, South Korea
[11] Sungkyunkwan Univ, Dept Hlth Sci & Technol, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
基金
新加坡国家研究基金会;
关键词
natural killer cells; expansion; IL-21; K562; OX40; ligand; NATURAL-KILLER-CELLS; T-CELLS; EX-VIVO; ACTIVATION; CD4;
D O I
10.3389/fimmu.2019.00879
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction. Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4-5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells. Results: The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation. Conclusion: Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion.
引用
收藏
页数:12
相关论文
共 27 条
  • [1] Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21
    Thangaraj, Jaya Lakshmi
    Minh-Trang Thi Phan
    Kweon, SoonHo
    Kim, Jinho
    Lee, Jong-Min
    Hwang, Ilwoong
    Park, Jeehun
    Doh, Junsang
    Lee, Seung-Hwan
    Manh-Cuong Vo
    Tan-Huy Chu
    Song, Ga-Young
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Kim, Hyeoung-Joon
    Cho, Duck
    Lee, Je-Jung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 613 - 625
  • [2] Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21
    Jiang, Bo
    Wu, Xuan
    Li, Xi-ning
    Yang, Xi
    Zhou, Yulai
    Yan, Haowei
    Wei, An-hui
    Yan, Weiqun
    CELLULAR IMMUNOLOGY, 2014, 290 (01) : 10 - 20
  • [3] Retroviral gene transfer into primary human NK cells activated by IL-2 and K562 feeder cells expressing membrane-bound IL-21
    Streltsova, Maria A.
    Barsov, Eugene
    Erokhina, Sofia A.
    Kovalenko, Elena I.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2017, 450 : 90 - 94
  • [4] Multiple effects of IL-21 on human NK cells in ex vivo expansion
    Li, Qi
    Ye, Lin-Jie
    Ren, Hai-Long
    Ting Huyan
    Li, Jing
    Shi, Jun-Ling
    Huang, Qing-Sheng
    IMMUNOBIOLOGY, 2015, 220 (07) : 876 - 888
  • [5] Selective Expansion of NKG2C+Adaptive NK Cells Using K562 Cells Expressing HLA-E
    Phan, Minh-Trang Thi
    Kim, Jinho
    Koh, Seung Kwon
    Lim, Yuree
    Yu, Hongbi
    Lee, Mijeong
    Lee, Jong-Min
    Kang, Eun-Suk
    Kim, Hyun-Young
    Kim, Sang-Ki
    Hwang, Ilwoong
    Cho, Duck
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [6] Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
    Ojo, Evelyn O.
    Sharma, Ashish Arunkumar
    Liu, Ruifu
    Moreton, Stephen
    Checkley-Luttge, Mary-Ann
    Gupta, Kalpana
    Lee, Grace
    Lee, Dean A.
    Otegbeye, Folashade
    Sekaly, Rafick-Pierre
    de Lima, Marcos
    Wald, David N.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
    Kloss, Stephan
    Oberschmidt, Olaf
    Morgan, Michael
    Dahlke, Julia
    Arseniev, Lubomir
    Huppert, Volker
    Granzin, Markus
    Gardlowski, Tanja
    Matthies, Nadine
    Soltenborn, Stephanie
    Schambach, Axel
    Koehl, Ulrike
    HUMAN GENE THERAPY, 2017, 28 (10) : 897 - 913
  • [8] Simvastatin Reduces OX40 and OX40 Ligand Expression in Human Peripheral Blood Mononuclear Cells and in Patients with Atherosclerotic Cerebral Infarction
    Liu, B.
    Yu, G.
    Yang, Z.
    Sun, L.
    Song, R.
    Liu, F.
    Xin, Y.
    Zhang, L.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (03) : 601 - 610
  • [9] Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A
    Streltsova, Maria A.
    Erokhina, Sofya A.
    Kanevskiy, Leonid M.
    Lee, Dean A.
    Telford, William G.
    Sapozhnikov, Alexander M.
    Kovalenko, Elena, I
    PLOS ONE, 2018, 13 (12):
  • [10] Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
    Granzin, Markus
    Stojanovic, Ana
    Miller, Matthias
    Childs, Richard
    Huppert, Volker
    Cerwenka, Adelheid
    ONCOIMMUNOLOGY, 2016, 5 (09):